News

JUNS
Jupiter Neurosciences, Inc. News

This news view pulls recent coverage and headlines tied to JUNS.

Latest Close

$0.17

1y Change

-$1.60 (-90.68%)

Market Cap

$7,956,979.00

Sector

Healthcare

Industry

Biotechnology

Recommendation

none

Jupiter Neurosciences Strengthens Board with Appointment of Dr. Tomas J. Philipson

GlobeNewswire • Jul 7, 2026

Read article

Top Premarket Decliners

MT Newswires • Jun 29, 2026

Read article

Presenting on Emerging Growth Conference 93 Day 1 on June 10; Register to live stream

GlobeNewswire • Jun 9, 2026

Read article

D. Boral Capital Acted as Exclusive Placement Agent to Jupiter Neurosciences, Inc. (Nasdaq:JUNS) in Connection with its ~$2 Million Registered Direct Offering

ACCESS Newswire • May 26, 2026

Read article

BC-Most Active Stocks

Associated Press • May 21, 2026

Read article

Jupiter Neurosciences Announces Pricing of $2.0 Million Registered Direct Offering

GlobeNewswire • May 20, 2026

Read article